Literature DB >> 33469266

Preparation and Characterization of Tacrolimus-Loaded SLNs in situ Gel for Ocular Drug Delivery for the Treatment of Immune Conjunctivitis.

Kexin Sun1, Ke Hu1.   

Abstract

BACKGROUND: The aim of this study is to develop a novel in situ gel of tacrolimus-loaded SLNs (solid lipid nanoparticles) for ocular drug delivery.
METHODS: The optimal formulation was characterized by surface morphology, particle size, zeta potential, entrapment efficiency, drug loading and in vitro release behavior. In vivo studies were also conducted to evaluate the pharmacokinetic and pharmacodynamic results.
RESULTS: In this study, TAC-SLNs ISG were prepared using homogenization followed by probe sonication method. The average particle size of TAC-SLNs ISG was observed to be 122.3±4.3 nm. Compared with TAC-SLNs, in situ gel did not increase particle size, and there was no significant difference between them. The results of viscosity measurement showed that TAC SLNs-ISG were typical of pseudo plastic systems and showed a marked increase in viscosity as temperature increased and ultimately formed a rigid gel (32°C). In vitro and in vivo studies illustrated the sustained release model of the drug from TAC-SLNs ISG. Animal model showed that TAC-SLNs ISG had good pharmacodynamics when compared with eye drops and SLNs.
CONCLUSION: Our results demonstrated that TAC SLNs-ISG had the potential for being an ideal ocular drug delivery system.
© 2021 Sun and Hu.

Entities:  

Keywords:  SLNs; in situ gel; ocular drug delivery; tacrolimus

Mesh:

Substances:

Year:  2021        PMID: 33469266      PMCID: PMC7811375          DOI: 10.2147/DDDT.S287721

Source DB:  PubMed          Journal:  Drug Des Devel Ther        ISSN: 1177-8881            Impact factor:   4.162


  26 in total

Review 1.  Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

Authors:  R H Müller; K Mäder; S Gohla
Journal:  Eur J Pharm Biopharm       Date:  2000-07       Impact factor: 5.571

2.  For the special IJP issue "poorly soluble drugs".

Authors:  Thorsteinn Loftsson; Anette Muellertz; Juergen Siepmann
Journal:  Int J Pharm       Date:  2013-06-03       Impact factor: 5.875

3.  Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.

Authors:  Narendar Dudhipala; Kishan Veerabrahma
Journal:  Drug Deliv       Date:  2014-05-28       Impact factor: 6.419

Review 4.  Recent advances in topical nano drug-delivery systems for the anterior ocular segment.

Authors:  Prit Lakhani; Akash Patil; Soumyajit Majumdar
Journal:  Ther Deliv       Date:  2018-02

5.  Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues.

Authors:  Sai Prachetan Balguri; Goutham R Adelli; Soumyajit Majumdar
Journal:  Eur J Pharm Biopharm       Date:  2016-10-25       Impact factor: 5.571

6.  Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system.

Authors:  B Srividya; R M Cardoza; P D Amin
Journal:  J Control Release       Date:  2001-06-15       Impact factor: 9.776

7.  Evaluation, synthesis and characterization of tacrolimus impurities.

Authors:  Patrizia Ferraboschi; Diego Colombo; Maria De Mieri; Paride Grisenti
Journal:  J Antibiot (Tokyo)       Date:  2012-04-18       Impact factor: 2.649

8.  Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity.

Authors:  Angela M de Campos; Yolanda Diebold; Edison L S Carvalho; Alejandro Sánchez; Maria José Alonso
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.200

Review 9.  A review on recent drug delivery systems for posterior segment of eye.

Authors:  Kritika Nayak; Manju Misra
Journal:  Biomed Pharmacother       Date:  2018-09-05       Impact factor: 6.529

10.  Increased brain radioactivity by intranasal P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gels.

Authors:  Ana Paula Perez; Cecilia Mundiña-Weilenmann; Eder Lilia Romero; Maria Jose Morilla
Journal:  Int J Nanomedicine       Date:  2012-03-12
View more
  3 in total

Review 1.  Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System.

Authors:  Md Habban Akhter; Irfan Ahmad; Mohammad Y Alshahrani; Alhanouf I Al-Harbi; Habibullah Khalilullah; Obaid Afzal; Abdulmalik S A Altamimi; Shehla Nasar Mir Najib Ullah; Abhijeet Ojha; Shahid Karim
Journal:  Gels       Date:  2022-01-28

2.  Formulation and Evaluation of Nano Lipid Carrier-Based Ocular Gel System: Optimization to Antibacterial Activity.

Authors:  Sadaf Jamal Gilani; May Nasser Bin Jumah; Ameeduzzafar Zafar; Syed Sarim Imam; Mohd Yasir; Mohammad Khalid; Sultan Alshehri; Mohammed M Ghuneim; Fatima M Albohairy
Journal:  Gels       Date:  2022-04-21

Review 3.  Ocular Nanomedicine.

Authors:  Zhimin Tang; Xianqun Fan; Yu Chen; Ping Gu
Journal:  Adv Sci (Weinh)       Date:  2022-02-12       Impact factor: 17.521

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.